A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy

医学 肝细胞癌 无线电技术 内科学 化疗 肿瘤科 放射科
作者
Xuelei He,Kai Li,Ran Wei,Mengxuan Zuo,Wang Yao,Zechen Zheng,Xiaowei He,Yan Fu,Chengzhi Li,Chao An,Wendao Liu
出处
期刊:Radiologia Medica [Springer Science+Business Media]
卷期号:128 (12): 1508-1520 被引量:17
标识
DOI:10.1007/s11547-023-01719-1
摘要

Abstract Background The macrotrabecular-massive (MTM) is a special subtype of hepatocellular carcinoma (HCC), which has commonly a dismal prognosis. This study aimed to develop a multitask deep learning radiomics (MDLR) model for predicting MTM and HCC patients’ prognosis after hepatic arterial infusion chemotherapy (HAIC). Methods From June 2018 to March 2020, 158 eligible patients with HCC who underwent surgery were retrospectively enrolled in MTM related cohorts, and 752 HCC patients who underwent HAIC were included in HAIC related cohorts during the same period. DLR features were extracted from dual-phase (arterial phase and venous phase) contrast-enhanced computed tomography (CECT) of the entire liver region. Then, an MDLR model was used for the simultaneous prediction of the MTM subtype and patient prognosis after HAIC. The MDLR model for prognostic risk stratification incorporated DLR signatures, clinical variables and MTM subtype. Findings The predictive performance of the DLR model for the MTM subtype was 0.968 in the training cohort [TC], 0.912 in the internal test cohort [ITC] and 0.773 in the external test cohort [ETC], respectively. Multivariable analysis identified portal vein tumor thrombus (PVTT) ( p = 0.012), HAIC response ( p < 0.001), HAIC sessions ( p < 0.001) and MTM subtype ( p < 0.001) as indicators of poor prognosis. After incorporating DLR signatures, the MDLR model yielded the best performance among all models (AUC, 0.855 in the TC, 0.805 in the ITC and 0.792 in the ETC). With these variables, the MDLR model provided two risk strata for overall survival (OS) in the TC: low risk (5-year OS, 44.9%) and high risk (5-year OS, 4.9%). Interpretation A tool based on MDLR was developed to consider that the MTM is an important prognosis factor for HCC patients. MDLR showed outstanding performance for the prognostic risk stratification of HCC patients who underwent HAIC and may help physicians with therapeutic decision making and surveillance strategy selection in clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zgt01发布了新的文献求助10
1秒前
zhang完成签到,获得积分10
1秒前
江中完成签到 ,获得积分10
3秒前
3秒前
阿玖完成签到 ,获得积分10
4秒前
jiaolulu发布了新的文献求助10
6秒前
踏雪飞鸿完成签到,获得积分10
7秒前
hannah完成签到,获得积分10
7秒前
songvv发布了新的文献求助10
8秒前
一一一应助Bin_Liu采纳,获得10
9秒前
麻果完成签到,获得积分10
11秒前
OER完成签到,获得积分10
11秒前
伦语完成签到,获得积分20
11秒前
中陆完成签到,获得积分10
12秒前
13秒前
莫西莫西完成签到,获得积分10
15秒前
17秒前
量子星尘发布了新的文献求助10
18秒前
xjh完成签到,获得积分10
18秒前
18秒前
lbnzd8g完成签到,获得积分10
20秒前
中海完成签到,获得积分10
20秒前
Ww完成签到,获得积分10
20秒前
伶俐不二完成签到,获得积分10
20秒前
XIAOJU_U完成签到 ,获得积分10
21秒前
马士全发布了新的文献求助10
22秒前
MQ完成签到,获得积分10
22秒前
单纯血茗发布了新的文献求助10
24秒前
善学以致用应助田南松采纳,获得10
24秒前
不如看海完成签到 ,获得积分10
25秒前
可靠的南露完成签到,获得积分10
26秒前
gg完成签到,获得积分10
26秒前
AU完成签到,获得积分10
28秒前
与淇完成签到,获得积分10
28秒前
开心祯祯完成签到,获得积分10
28秒前
马士全完成签到,获得积分10
29秒前
Qian完成签到 ,获得积分10
29秒前
degre完成签到 ,获得积分10
29秒前
W~舞完成签到,获得积分10
30秒前
我的文献呢应助pz采纳,获得30
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038201
求助须知:如何正确求助?哪些是违规求助? 3575940
关于积分的说明 11373987
捐赠科研通 3305747
什么是DOI,文献DOI怎么找? 1819274
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022